Current Position and Role
Christina Sonnenborg Bredal serves as Executive Vice President (EVP) and Chief People Officer at Zealand Pharma A/S, a position she has held since February 2024. She joined Zealand Pharma in 2020, initially appointed as Head of People & Organization, before her promotion to EVP and Chief People Officer. In this executive role, Christina leads the company's people function, overseeing organizational development, talent management, and employee engagement across the enterprise. She is a core member of Zealand Pharma’s Corporate Management team, responsible for shaping and implementing the company's human capital strategies essential to sustaining growth and innovation.
Professional Background and Experience
Christina has accumulated over 10 years of experience in legal and advisory roles, providing her with a solid foundation in corporate governance, compliance, and people management. Her expertise enables her to integrate legal, organizational, and leadership functions effectively in the biotech industry context. Prior to joining Zealand Pharma, she developed competencies that complement her current responsibilities in leading the people and organizational strategy.
Contributions and Responsibilities
- Spearheads the People & Organization function, driving initiatives to attract, develop, and retain top talent within the peptide therapeutics sector.
- Instrumental in leadership development and mentoring programs, positioning employees and managers to meet business challenges effectively.
- Integral to Zealand Pharma’s commitment to diversity and inclusion, contributing to balanced workforce distributions; as of 2021 reporting, the company maintained 17% women and 83% men under her leadership in HR-related functions.
- Acts as a company representative at industry events and awards, notably alongside other senior executives such as the Chief Operations Officer, showcasing Zealand Pharma’s market position and corporate culture in public forums.
Personal and Demographic Information
- Year of Birth: 1985
- Nationality: Danish
- Location: Copenhagen, Denmark
Zealand Pharma Overview Relevant to Role
Zealand Pharma is a publicly traded biotechnology company (Nasdaq: ZEAL) with a focus on discovery, design, and development of peptide therapeutics. As of recent reports (2023–2024), the company marked 25 years of operations, highlighting a strong heritage and leadership in the peptide therapeutics and obesity therapeutics markets. The company has achieved significant milestones such as its first FDA approval and preparing for product launches including Zegalogue (dasiglucagon injection).
Christina’s role as EVP/Chief People Officer is critical in supporting Zealand Pharma’s growth trajectory by ensuring that organizational structures and talent strategies align with the company’s ambitions in innovative therapeutic development. Her leadership in human capital directly supports Zealand's success in navigating regulatory milestones, expanding pipelines, and maintaining corporate governance aligned with stakeholder expectations.
Industry Recognition and Visibility
Christina has participated in and represented Zealand Pharma at prominent industry events including the European Mediscience Awards, which convene leading private and publicly quoted healthcare, biotech, and life science companies across Europe. This involvement underscores her role not only in internal human capital leadership but also as a figurehead in Zealand’s external corporate profile.
This dossier consolidates available data on Christina Sonnenborg Bredal, emphasizing her strategic leadership in human resources and organizational management within Zealand Pharma’s biopharmaceutical environment, illustrating her pivotal role in driving workforce excellence that underpins Zealand Pharma’s scientific and commercial success.
